Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Coherus BioSciences, Inc. (8C5.F)

Compare
0.8802
-0.0402
(-4.37%)
At close: April 17 at 8:01:18 AM GMT+2

Valuation Measures

Annual Monthly
Currency in EUR Download
Current12/31/20249/30/20246/30/20243/31/202412/31/2023
Market Cap 113.91M 165.72M 107.28M 185.35M 249.16M 335.12M
Enterprise Value 240.20M 330.83M 206.18M 392.10M 584.98M 649.24M
Trailing P/E 4.01 -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 0.43 0.59 0.39 0.61 0.87 1.34
Price/Book -- -- -- -- -- --
Enterprise Value/Revenue 1.03 1.13 0.75 1.39 2.46 3.40
Enterprise Value/EBITDA 4.49 9.25 18.76 -- -- -9.55
12/31/2023 - 11/22/2022

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2024
Most Recent Quarter (mrq) 12/31/2024

Profitability

Profit Margin 10.68%
Operating Margin (ttm) -65.65%

Management Effectiveness

Return on Assets (ttm) -10.94%
Return on Equity (ttm) --

Income Statement

Revenue (ttm) 266.96M
Revenue Per Share (ttm) 2.33
Quarterly Revenue Growth (yoy) -40.80%
Gross Profit (ttm) 149.41M
EBITDA -89.09M
Net Income Avi to Common (ttm) 28.51M
Diluted EPS (ttm) 0.2200
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 125.99M
Total Cash Per Share (mrq) 1.09
Total Debt (mrq) 298.65M
Total Debt/Equity (mrq) --
Current Ratio (mrq) 1.21
Book Value Per Share (mrq) -1.14

Cash Flow Statement

Operating Cash Flow (ttm) -20.44M
Levered Free Cash Flow (ttm) 41.59M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52 Week Change 3 -53.18%
S&P 500 52-Week Change 3 6.35%
52 Week High 3 2.1200
52 Week Low 3 0.6062
50-Day Moving Average 3 0.9115
200-Day Moving Average 3 1.1060

Share Statistics

Avg Vol (3 month) 3 535
Avg Vol (10 day) 3 460
Shares Outstanding 5 115.9M
Implied Shares Outstanding 6 129.41M
Float 8 114.41M
% Held by Insiders 1 6.54%
% Held by Institutions 1 57.59%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending